Welcome to our dedicated page for MOODYS /DE/ SEC filings (Ticker: MCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MOODYS /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MOODYS /DE/'s regulatory disclosures and financial reporting.
Moody's Corporation director Therese Esperdy reported a small automatic increase in her holdings due to dividend-related awards on 12/12/2025. She acquired 8.222 shares of common stock as an RSU deferred dividend reinvestment accrual at a price of $486.745 per share, bringing her directly held common stock to 4,700.662 shares.
She also received 0.845 dividend equivalent derivative units tied to an exempt grant of unvested RSUs, representing the right to receive the same number of common shares when the underlying RSUs vest and settle. After this transaction, she holds 3.423 dividend equivalent derivative securities in total, all reported as directly owned.
Moody's Corporation director Jorge A. Bermudez reported small automatic acquisitions of company stock. On December 12, 2025, he acquired 16 shares of common stock through restricted stock deferred dividend reinvestment and 1.193 shares through RSU deferred dividend reinvestment. Following these transactions, he directly beneficially owned 22,396.77 shares of Moody's common stock. No derivative securities were reported in this filing.
Moody's Corporation President and CEO Robert Fauber reported an automatic option exercise and share sale. On 12/03/2025, he exercised an employee stock option to acquire 575 shares of Moody's common stock at an exercise price of $167.50 per share, then sold 575 shares at a price of $487.87 per share on the same day. These transactions were made under a Rule 10b5-1 trading plan that he adopted on July 30, 2025, which is designed to pre-arrange trades. After the transactions, Fauber directly owned 61,081.984 shares of common stock and held 5,172 employee stock options that remain beneficially owned.
An insider of MCO filed a Rule 144 notice to sell 575 common shares through Fidelity Brokerage Services on the NYSE. The filing notes that 178,400,000 common shares were outstanding at the time referenced. The seller previously sold multiple small common-share blocks over the past three months, including 1,167 shares on 11/03/2025 and 592 shares on 12/01/2025. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
Moody's Corporation President and CEO Robert Fauber reported an option exercise and matching share sale in company stock. On 12/01/2025 he exercised 592 employee stock options with an exercise price of $113.34 per share, receiving the same number of Moody's common shares. That same day he sold 592 common shares at a price of $486.09 per share. After these transactions, Fauber beneficially owned 61,081.984 Moody's common shares directly and held 4,787 employee stock options that remain outstanding. The filing states these trades were made under a Rule 10b5-1 trading plan adopted by Fauber on July 30, 2025, which is designed to pre‑schedule transactions.
Moody’s Corporation (MCO) President and CEO Robert Fauber reported option exercises and a share sale executed under a Rule 10b5-1 plan.
On 11/03/2025, he exercised options for 592 shares at $113.34 and 575 shares at $167.5, then sold 1,167 common shares at $478.95. Following these transactions, he beneficially owned 61,081.984 common shares. The Rule 10b5-1 plan was adopted on July 30, 2025.
MCO received a Form 144 notice for a proposed sale of 1,167 shares of its common stock with an aggregate market value of $558,934.65. The shares are listed on the NYSE and the filing lists Fidelity Brokerage Services LLC as broker, with an approximate sale date of 11/03/2025.
The seller indicates the shares were acquired on 11/03/2025 via employee stock options originally granted on 02/23/2017 and 02/16/2018, in amounts of 592 and 575 shares, respectively, with cash payment. Recent activity shows sales in the prior three months, including 546 shares for $269,669.40 on 10/28/2025. Shares outstanding were 178,400,000.
Moody’s Corporation (MCO) officer Richard G. Steele reported an open‑market sale of 26 shares of common stock on 10/28/2025 at a price of $493.9 per share. The filing notes the sale was made pursuant to a Rule 10b5‑1 trading plan adopted on July 29, 2025.
Following the transaction, Steele reported 1,333.722 shares held directly and 3,612.666 shares held indirectly through a trust. Steele serves as SVP – General Counsel of Moody’s.
Moody’s Corporation (MCO) insider activity: President and CEO, and Director, Robert Fauber reported exercising employee stock options and selling shares on 10/28/2025 under a Rule 10b5-1 plan adopted on July 30, 2025.
He exercised 546 options at $113.34 (Code M) and sold 546 common shares at $493.90 (Code S). Following these transactions, he beneficially owned 61,081.984 common shares directly. His derivative holdings included 5,971 employee stock options. The option grant vests in four equal annual installments beginning on 02/23/2018 and expires on 02/23/2027.
Moody’s Corporation (MCO) filed a Form 144 indicating a proposed sale of 546 common shares through Fidelity Brokerage Services LLC, with an aggregate market value $269,669.40. The filing lists an approximate sale date of 10/28/2025 on the NYSE. The table also notes 178,400,000 shares outstanding.
The shares to be sold were acquired via an option granted on 02/23/2017, with cash payment dated 10/28/2025. Recent sales disclosed for the same seller over the past three months include 415 shares on 08/01/2025 for $211,728.85 and 415 shares on 08/15/2025 for $216,401.75, among other similar transactions.